All sites C00-96,D32-33,D42-43,D45-47,D76 4270 90.9 3.2 2.7 1.0 2.1
Mouth, pharynx C00-14 64 96.9 0.9 0.6 0.3 1.3
  Lip C00 7 100.0 - - - -
  Tongue C02 14 97.1 - - 1.4 1.4
  Mouth, other C03-06 21 99.0 - - - 1.0
  Salivary glands C07-08 7 91.7 2.8 5.6 - -
  Pharynx C01,C09-14 15 94.7 2.6 - - 2.6
Digestive organs C15-26 697 82.6 4.2 7.2 2.2 3.8
  Oesophagus C15 25 93.7 - 0.8 3.2 2.4
  Stomach C16 58 94.2 0.7 1.4 1.4 2.4
  Small intestine C17 17 88.5 1.1 3.4 2.3 4.6
  Colon C18 251 95.9 0.2 1.8 0.4 1.7
  Rectum, rectosigmoid C19-20 110 97.3 - 2.0 0.4 0.4
  Anus C21 10 98.0 - - 2.0 -
  Liver C22 43 70.2 7.0 13.5 4.7 4.7
  Gallbladder, bile ducts C23-24 29 63.4 9.7 11.7 4.1 11.0
  Pancreas C25 139 49.6 15.9 21.6 5.2 7.8
  Other digestive organs C26 14 47.1 1.5 19.1 8.8 23.5
Respiratory organs C30-39 301 64.6 17.0 10.8 2.9 4.6
  Nose, sinuses C30-31 6 93.3 - 3.3 3.3 -
  Larynx, epiglottis C32 5 96.2 - 3.8 - -
  Lung, trachea C33-34 283 64.0 17.8 10.9 3.0 4.2
  Mediastinum, pleura C38 3 41.2 23.5 23.5 - 11.8
Bone C40-41 5 100.0 - - - -
Melanoma of the skin C43 230 99.9 - - - 0.1
Skin, non-melanoma C44 183 99.9 - - 0.1 -
Mesothelioma C45 7 100.0 - - - -
Autonomic nervous system C47 1 100.0 - - - -
Soft tissues C48-49 37 96.8 2.7 - - 0.5
Breast C50 1418 99.6 0.1 0.0 0.1 0.1
Female genital organs C51-58 425 94.4 2.5 1.4 0.6 1.2
  Cervix uteri C53 43 98.1 0.9 - 0.9 -
  Corpus uteri C54 198 99.1 - 0.4 0.1 0.4
  Uterus, other C55,C58 2 58.3 8.3 8.3 - 25.0
  Ovary C56 114 88.4 5.6 2.8 1.1 2.1
  Other female genital C51-52,C57 68 89.4 5.3 2.3 1.2 1.8
Urinary organs C64-68 171 89.0 1.6 4.6 1.8 3.0
  Kidney C64 97 86.2 1.2 6.8 2.1 3.7
  Bladder and urinary tract2 C65-68 74 92.7 2.2 1.6 1.4 2.2
Eye C69 4 72.7 - 18.2 4.5 4.5
Brain, central nervous system C70-72,D32-33,D42-43 175 95.1 - 2.5 0.6 1.8
Thyroid gland C73 100 97.0 2.2 0.4 0.2 0.2
Other endocrine glands C74-75 7 97.0 - - - 3.0
Illdefined or unknown C76,C80 78 55.4 13.9 13.9 5.2 11.6
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 369 83.8 7.4 0.8 1.6 6.4
  Hodgkin lymphoma C81 15 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 170 97.4 0.7 0.2 0.2 1.4
  Malignant immunoproliferative diseases C88 5 91.3 4.3 - 4.3 -
  Myeloma and other plasma cell tumors C90 54 80.5 5.5 3.7 2.9 7.4
  Leukaemia C91-95 74 68.3 19.2 - 3.0 9.5
  Myelodysplastic syndromes D46 16 32.1 18.5 - 6.2 43.2
  Myeloproliferaitive neoplasms D45,D47 34 70.9 16.3 1.7 1.7 9.3
Not included above
  Carcinoma in situ of the breast D05 118 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 275 100.0 - - - -
  Borderline tumour of the ovary D39 38 94.7 - 2.1 - 3.2
  Basal cell carcinoma of the skin 1325 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.